Our cancer vaccine development support team will apply a comprehensive methodology to evaluate the carbohydrate, lipopolysaccharide, lipid, protein, glycoprotein, and lipoprotein components of the vaccine. Our experts use advanced technology platforms such as high-resolution mass spectrometry (HRMS) and nuclear magnetic resonance (NMR) to carry out vaccine development and research, including vaccine stability research and vaccine release testing. To help clients obtain an accurate data report for the projects, we provide comprehensive quality assurance expertise in compliance with the regulatory standards of quality and safety.
Provide comprehensive quality assurance expertise to help you meet and exceed quantity, stability and purity.
We are committed to proving the vaccine products that have acceptable quality, efficacy and safety under certain storage conditions.
The vaccine production process includes extensive process and release testing to ensure consistency in product quality and performance.
With our rich experience and advanced platform, we are confident to provide the best development services for vaccine microbiological testing.
Please feel free to contact us and get more detailed information.
Related Analytical Characterization for Cancer Vaccines：
For any technical issues or products/services related questions, please leave your contacts as below, and our team will contact you at earliest convenience to let you know how we can be involved in your projects.
Nanoparticle Tiny Tech for Programming T Cells: A novel technology to increase the efficiency and value of your CAR-T therapy project.LEARN MORE
End-to-end CAR Hybrid TCR (CHyT)-T Cell Therapy Development Services: A novel solution to engineer T cell to be a promising cellular therapy with the complete TCR without HLA dependence.LEARN MORE
TRAC-CAR-T Cell Development with CRISPR/Cas9 Technology: A novel technology to build more powerful CAR-T cells.LEARN MORE